Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy.
Mastellos DC, Pires da Silva BGP, Fonseca BAL, Fonseca NP, Auxiliadora-Martins M, Mastaglio S, Ruggeri A, Sironi M, Radermacher P, Chrysanthopoulou A, Skendros P, Ritis K, Manfra I, Iacobelli S, Huber-Lang M, Nilsson B, Yancopoulou D, Connolly ES, Garlanda C, Ciceri F, Risitano AM, Calado RT, Lambris JD. Mastellos DC, et al. Among authors: mastaglio s. Clin Immunol. 2020 Nov;220:108598. doi: 10.1016/j.clim.2020.108598. Epub 2020 Sep 19. Clin Immunol. 2020. PMID: 32961333 Free PMC article.
Progress and prospects: graft-versus-host disease.
Mastaglio S, Stanghellini MT, Bordignon C, Bondanza A, Ciceri F, Bonini C. Mastaglio S, et al. Gene Ther. 2010 Nov;17(11):1309-17. doi: 10.1038/gt.2010.83. Epub 2010 May 27. Gene Ther. 2010. PMID: 20508597 Review.
Improving the safety of cell therapy with the TK-suicide gene.
Greco R, Oliveira G, Stanghellini MT, Vago L, Bondanza A, Peccatori J, Cieri N, Marktel S, Mastaglio S, Bordignon C, Bonini C, Ciceri F. Greco R, et al. Among authors: mastaglio s. Front Pharmacol. 2015 May 5;6:95. doi: 10.3389/fphar.2015.00095. eCollection 2015. Front Pharmacol. 2015. PMID: 25999859 Free PMC article. Review.
Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide.
Greco R, Lorentino F, Nitti R, Lupo Stanghellini MT, Giglio F, Clerici D, Xue E, Lazzari L, Piemontese S, Mastaglio S, Assanelli A, Marktel S, Corti C, Bernardi M, Ciceri F, Peccatori J. Greco R, et al. Among authors: mastaglio s. Front Immunol. 2019 Oct 1;10:2319. doi: 10.3389/fimmu.2019.02319. eCollection 2019. Front Immunol. 2019. PMID: 31632401 Free PMC article.
The first case of COVID-19 treated with the complement C3 inhibitor AMY-101.
Mastaglio S, Ruggeri A, Risitano AM, Angelillo P, Yancopoulou D, Mastellos DC, Huber-Lang M, Piemontese S, Assanelli A, Garlanda C, Lambris JD, Ciceri F. Mastaglio S, et al. Clin Immunol. 2020 Jun;215:108450. doi: 10.1016/j.clim.2020.108450. Epub 2020 Apr 29. Clin Immunol. 2020. PMID: 32360516 Free PMC article.
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.
Lupo-Stanghellini MT, Xue E, Mastaglio S, Oltolini C, Angelillo P, Messina C, Piemontese S, Girlanda S, Farina F, Lazzari L, Cicalese MP, Erbella F, Greco R, Locatelli M, Milani R, Peccatori J, Corti C, Marktel S, Assanelli A, Ciceri F. Lupo-Stanghellini MT, et al. Among authors: mastaglio s. Bone Marrow Transplant. 2021 Sep;56(9):2312-2315. doi: 10.1038/s41409-021-01278-x. Epub 2021 Jun 30. Bone Marrow Transplant. 2021. PMID: 34193980 Free PMC article. No abstract available.
Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial.
Lazzari L, Ruggeri A, Lupo Stanghellini MT, Mastaglio S, Messina C, Giglio F, Lorusso A, Perini T, Piemontese S, Marcatti M, Lorentino F, Xue E, Clerici D, Corti C, Bernardi M, Assanelli A, Greco R, Ciceri F, Peccatori J. Lazzari L, et al. Among authors: mastaglio s. Front Oncol. 2021 Sep 10;11:731478. doi: 10.3389/fonc.2021.731478. eCollection 2021. Front Oncol. 2021. PMID: 34568066 Free PMC article.
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation.
Lorentino F, Xue E, Mastaglio S, Giglio F, Clerici D, Farina F, Piemontese S, Bruno A, Lazzari L, Ruggeri A, Guggiari E, Lunghi F, Assanelli AA, Marktel S, Marcatti M, Carrabba MG, Bernardi M, Corti C, Peccatori J, Ciceri F, Greco R, Lupo-Stanghellini MT. Lorentino F, et al. Among authors: mastaglio s. Blood Adv. 2022 May 24;6(10):3053-3057. doi: 10.1182/bloodadvances.2021006213. Blood Adv. 2022. PMID: 35078219 Free PMC article. No abstract available.
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience.
Piemontese S, Lazzari L, Ruggeri A, Marcatti M, Lupo Stanghellini MT, Giglio F, Greco R, Lorentino F, Clerici D, Assanelli A, Farina F, Mastaglio S, Xue E, Marktel S, Vago L, Gentner B, Secco C, Corti C, Carrabba MG, Bernardi M, Peccatori J, Ciceri F. Piemontese S, et al. Among authors: mastaglio s. Bone Marrow Transplant. 2022 Apr;57(4):678-680. doi: 10.1038/s41409-022-01600-1. Epub 2022 Feb 5. Bone Marrow Transplant. 2022. PMID: 35124695 No abstract available.
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study.
Xue E, Lorentino F, Lupo Stanghellini MT, Giglio F, Piemontese S, Clerici DT, Farina F, Mastaglio S, Bruno A, Campodonico E, Nitti R, Marcatti M, Assanelli A, Corti C, Ciceri F, Peccatori J, Greco R. Xue E, et al. Among authors: mastaglio s. J Clin Med. 2022 Feb 19;11(4):1106. doi: 10.3390/jcm11041106. J Clin Med. 2022. PMID: 35207379 Free PMC article.
46 results